Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$763M |
| 2 |
Amazon
AMZN
|
+$688M |
| 3 |
TSMC
TSM
|
+$562M |
| 4 |
Tesla
TSLA
|
+$419M |
| 5 |
Johnson & Johnson
JNJ
|
+$398M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
Novo Nordisk
NVO
|
+$366M |
| 4 |
JPMorgan Chase
JPM
|
+$335M |
| 5 |
ASML
ASML
|
+$325M |
Sector Composition
| 1 | Healthcare | 20.8% |
| 2 | Technology | 15.52% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Consumer Staples | 10.11% |
| 5 | Financials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DBTX
3701
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $75K | ﹤0.01% |
36,394
+4,094
| +13% | +$8.44K |
|
|
HEPA
3702
DELISTED
Hepion Pharmaceuticals
HEPA
| $74K | ﹤0.01% |
246
+14
| +6% | +$4.21K |
|
|
MOGU
3703
MOGU Inc
MOGU
$37.7M
| $74K | ﹤0.01% |
30,057
+1,100
| +4% | +$2.71K |
|
3704
Vasta Platform
VSTA
$364M
| $74K | ﹤0.01% |
18,500
-1,500
| -8% | -$6K |
|
|
FUSN
3705
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $74K | ﹤0.01% |
23,500
+6,700
| +40% | +$21.1K |
|
|
AMAM
3706
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $74K | ﹤0.01% |
32,500
-31,500
| -49% | -$71.7K |
|
|
CNTB
3707
Connect Biopharma Holdings Limited Ordinary Shares
CNTB
$90.8M
| $73K | ﹤0.01% |
83,900
+600
| +0.7% | +$522 |
|
|
MDRR
3708
Medalist Diversified REIT
MDRR
$18.2M
| $73K | ﹤0.01% |
6,519
-1,606
| -20% | -$18K |
|
3709
Synlogic
SYBX
$17.2M
| $73K | ﹤0.01% |
6,427
-1,280
| -17% | -$14.5K |
|
|
ONCR
3710
DELISTED
Oncorus, Inc.
ONCR
| $73K | ﹤0.01% |
286,936
+77,403
| +37% | +$19.7K |
|
3711
Creative Realities
CREX
$24M
| $72K | ﹤0.01% |
41,433
-4,900
| -11% | -$8.52K |
|
|
JG
3712
Aurora Mobile
JG
$60.9M
| $72K | ﹤0.01% |
5,615
-290
| -5% | -$3.72K |
|
3713
US Gold Corp
USAU
$213M
| $72K | ﹤0.01% |
+15,100
| New | +$72K |
|
3714
Atlantic American Corp
AAME
$66.5M
| $71K | ﹤0.01% |
30,500
-1,100
| -3% | -$2.56K |
|
3715
electroCore
ECOR
$38.1M
| $71K | ﹤0.01% |
18,471
+1,143
| +7% | +$4.39K |
|
3716
IGC Pharma
IGC
$36.7M
| $71K | ﹤0.01% |
222,011
-98,889
| -31% | -$31.6K |
|
|
NCTY
3717
The9 Ltd
NCTY
$143M
| $71K | ﹤0.01% |
12,529
-4,720
| -27% | -$26.7K |
|
3718
Dolphin Entertainment
DLPN
$14M
| $70K | ﹤0.01% |
19,200
-700
| -4% | -$2.55K |
|
3719
Imunon
IMNN
$14.2M
| $70K | ﹤0.01% |
3,988
-115
| -3% | -$2.02K |
|
3720
KORE Group Holdings
KORE
$37.4M
| $70K | ﹤0.01% |
11,120
+2,820
| +34% | +$17.8K |
|
|
NEXI
3721
DELISTED
NexImmune, Inc. Common Stock
NEXI
| $70K | ﹤0.01% |
11,588
+11,080
| +2,181% | +$66.9K |
|
3722
Context Therapeutics
CNTX
$75M
| $69K | ﹤0.01% |
105,300
-25,288
| -19% | -$16.6K |
|
3723
Farmmi
FAMI
$2.35M
| $69K | ﹤0.01% |
1,784
+214
| +14% | +$8.28K |
|
3724
Quantum-Si Incorporated
QSI
$243M
| $69K | ﹤0.01% |
+37,556
| New | +$69K |
|
3725
Spire Global
SPIR
$304M
| $69K | ﹤0.01% |
8,950
-4,195
| -32% | -$32.3K |
|